Novel PKC theta small-molecule inhibitor for inhibiting graft-versus-host diseases
A small molecule inhibitor, graft-versus-host technology, applied in the field of biomedicine, can solve the problems of low knockout efficiency, unsatisfactory number and quality of T cells, and many uncontrollable factors, to promote promotion and industrialization, The effect of promoting clinical application
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0077] Example 1: Inhibitory effect of FL-1507 on GVHD induced by allogeneic T cell transplantation. We treated T cells of C57BL / 6 mice with FL1507 or cosolvent for 24 hours (0.5x10 6 ), infused into BALB / c mice irradiated with a lethal dose of radioisotope, and observed and detected the ratio of spleen cells to transplanted T cells on the 4th and 14th day respectively, and determined the survival curve of the mice. The results showed that the GVHD induced by T cells treated with FL-1507 was significantly lower than that of the control group. The survival rate of mice in the FL-1507 group was also significantly higher than that in the control group. Image 6 shown.
[0078] At the same time, refer to Figure 5 As shown, FL-1507 significantly inhibited the expression of transcription factor RelA and cytokine IL-2 caused by CD3 / 28 activation of TCR. Therefore, by inhibiting TCR signal transduction, FL-1507 has an excellent inhibitory effect on GVHD caused by allogeneic T cel...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com